The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the mammalian target of rapamycin (mTOR) Pathway. (2025). Research, Society and Development, 14(4), e4614448656. https://doi.org/10.33448/rsd-v14i4.48656